ORBIMED ADVISORS LLC 13D and 13G filings for Apollomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-15 4:38 pm Sale | 2024-08-13 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 500 0.050% | -85,655 (-99.42%) | Filing |
| 2024-05-22 7:32 pm Unchanged | 2024-05-20 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 86,155 7.900% | 0 (Unchanged) | Filing |
| 2023-11-29 4:20 pm Sale | 2023-11-27 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 86,155 9.600% | -9,177 (-9.63%) | Filing |
| 2023-11-20 4:21 pm Sale | 2023-11-16 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 95,332 18.100% | -67,000 (-41.27%) | Filing |
| 2023-11-01 5:08 pm Sale | 2023-10-30 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 162,332 18.100% | -18,105 (-10.03%) | Filing |
| 2023-10-02 4:41 pm Purchase | 2023-09-29 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 180,436 20.200% | 173,811 (+2623.32%) | Filing |
| 2023-04-11 7:10 pm Purchase | 2023-03-29 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 6,626 10.300% | 6,626 (New Position) | Filing |